Every Zipp story tagged #Dilution, newest first.
The reset wipes $220M of warrant value and lifts bitcoin per diluted share 8.8%, but only landed after a 17% two-day drop and a 38% YTD slide against both bitcoin and Strategy.
The immediate BTC-per-share math is essentially flat at the post-placement level, but full exercise of the four warrants attached to each new share would cut shareholder Bitcoin exposure by 24.1%,…
Behind the 25% drop: zero revenue, $2M cash, a Nasdaq delisting notice, and a deal that issues 10 new shares per existing one. The Saylor copy is the framing; the rescue is the substance.
The 1.19% real gain is a narrow reversal after two straight weeks of negative per-share yield, but $5.74M in new annualized preferred dividends keeps widening the senior claim stack.
Public buyers would fund nearly all of Bitari's $30M raise and walk away with 10% of equity, $6.31 of immediate dilution per share, and 40% of proceeds parked for an unnamed acquisition.
Share count is up 145% since year-end 2025 and just $1.80M of unrestricted cash remains, turning a convertible-financed treasury experiment into a textbook small-cap unwind.
The corporate ETH model faces a balance-sheet test: staking income can coexist with treasury losses, debt and shareholder dilution.
The corporate-treasury trade is being repriced as dilution and cash-flow strain challenge the idea that buying more Bitcoin alone lifts a stock.
The treasury trade that lifted BTC-tilted stocks for two years is fraying: Strategy's BTC Yield is sliding, Metaplanet sits below its coin value, and European entrants want more capital on unpriced…
Bitcoin-treasury investors are challenging dilution-funded buying as Strategy's BTC Yield slides and Metaplanet trades below the value of its coins.
Strategy's BTC Yield has rolled over, Metaplanet trades below the value of its own holdings, and the playbook of raising equity to buy more Bitcoin is breaking in front of retail.
The treasury-trade playbook that lifted Strategy's stock for two years is cracking: dilution is no longer rewarded, and a biotech is the latest to test how far shareholders will stretch.
The dilution machine is breaking. Two years of buy-buy-buy lifted treasury stocks; now shareholders are selling the equity because the math stopped working.
Treasury stocks trading below the value of their coins are supposed to be screaming buys. The catch is dilution: every new share printed to buy more BTC erases the discount.
BTC Yield is sliding, Metaplanet trades below its coin hoard, and the funding shortcut that turned treasury companies into a $100B trade is now the reason the trade is breaking.
The size of the grant, roughly 5% of outstanding shares for two executives at a loss-making miner, lands as the more controversial figure than the dollar number alone.
The forced seller is a canary for the whole cohort: when refinancing tightens, the "buy more BTC" pitch stops working and the equity gets marked against NAV until the math clears.
Spot ETFs erased the scarcity premium that once made a leveraged Bitcoin wrapper worth holding, and shareholders are now rejecting dilution that used to get a free pass.
TheBlock
CryptoSlate
WuBlockchain